Six children with cryptosporidiosis, concurrently receiving chemotherapy for acute leukaemia (n=5) and lymphoma (n=1), are described. Two died with evidence of persistent infection. Modification of the chemotherapy regimens in the other four children was associated with successful eradication of the pathogen and permitted continued treatment of the primary disease.
Although the protozoal coccidian parasite, cryptosporidium, was first described as an animal pathogen in 1907, in more recent times it has been recognised increasingly as an important cause of diarrhoea in man. Surveys have shown it to be as frequent a cause of gastroenteritis as campylobacter, and more common than giardia, shigella, and salmonella. Cryptosporidiosis is a self limiting, although debilitating, disease in otherwise healthy people, but it may cause severe, intractable diarrhoea and malabsorption in immunosuppressed patients, and has been associated with a high mortality. In summary, cryptosporidiosis remains a life threatening infection in children who are immunosuppressed by chemotherapy, as documented by two deaths among the six cases described. Modification rather than cessation of chemotherapy regimens may lead to successful eradication of the organism, however, without leaving the child vulnerable to the primary disease.
We wish to thank Dr SF Gray for details of community outbreaks of cryptosporidiosis in the Bristol area, and the department of microbiology, Bristol Royal Infirmary, for help with laboratory diagnosis.
Dr ABM Foot is supported by the Alex Wolton Trust.
